WO2006064056A3 - Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide - Google Patents

Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide Download PDF

Info

Publication number
WO2006064056A3
WO2006064056A3 PCT/EP2005/056879 EP2005056879W WO2006064056A3 WO 2006064056 A3 WO2006064056 A3 WO 2006064056A3 EP 2005056879 W EP2005056879 W EP 2005056879W WO 2006064056 A3 WO2006064056 A3 WO 2006064056A3
Authority
WO
WIPO (PCT)
Prior art keywords
filtering device
nitric oxide
pathogen
cancer
disclosed
Prior art date
Application number
PCT/EP2005/056879
Other languages
French (fr)
Other versions
WO2006064056A2 (en
Inventor
Tor Peters
Original Assignee
Nolabs Ab
Tor Peters
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04029796A external-priority patent/EP1681068A1/en
Application filed by Nolabs Ab, Tor Peters filed Critical Nolabs Ab
Publication of WO2006064056A2 publication Critical patent/WO2006064056A2/en
Publication of WO2006064056A3 publication Critical patent/WO2006064056A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • A61M1/3633—Blood component filters, e.g. leukocyte filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood

Abstract

A filtering device and method are disclosed being adapted to eliminate, inactivate and/or remove pathogenic or cancerous elements, especially microorganisms, such as bacteria, parasites, fungi, mycoplasma, protozoa and viruses, or tumour cells from body fluids or fluids getting into contact with the body, by using NO originating from the filtering device material. Exemplary embodiments comprise blood filters, or breathing gas filters. Also, uses of nitric oxide are disclosed fro the treatment of various diseases, e.g. blood borne cancers, such as leukaemia.
PCT/EP2005/056879 2004-12-16 2005-12-16 Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide WO2006064056A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04029796.2 2004-12-16
EP04029796A EP1681068A1 (en) 2004-12-16 2004-12-16 Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
US63652704P 2004-12-17 2004-12-17
US60/636,527 2004-12-17

Publications (2)

Publication Number Publication Date
WO2006064056A2 WO2006064056A2 (en) 2006-06-22
WO2006064056A3 true WO2006064056A3 (en) 2006-08-17

Family

ID=36407940

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/056879 WO2006064056A2 (en) 2004-12-16 2005-12-16 Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide

Country Status (1)

Country Link
WO (1) WO2006064056A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2555552A1 (en) 2004-02-09 2005-09-09 Noxilizer, Inc. Nitric oxide-releasing molecules
WO2006128121A2 (en) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US20100040703A1 (en) * 2008-08-13 2010-02-18 Chris Miller Use of nitric oxide
GB0821345D0 (en) 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
WO2011022680A2 (en) 2009-08-21 2011-02-24 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042637A (en) * 1996-08-14 2000-03-28 Weinberg; Stanley Corona discharge device for destruction of airborne microbes and chemical toxins
US6261594B1 (en) * 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6656217B1 (en) * 1996-08-27 2003-12-02 Novovascular, Inc. Medical device coated with a polymer containing a nitric oxide releasing organometallic nitrosyl compound useful for the prevention of platelet aggregation
WO2004012874A1 (en) * 2002-08-02 2004-02-12 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same
US20040093015A1 (en) * 2002-08-01 2004-05-13 Ogle Matthew F. Embolism protection devices
US20040131753A1 (en) * 1999-10-08 2004-07-08 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses therefor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042637A (en) * 1996-08-14 2000-03-28 Weinberg; Stanley Corona discharge device for destruction of airborne microbes and chemical toxins
US6656217B1 (en) * 1996-08-27 2003-12-02 Novovascular, Inc. Medical device coated with a polymer containing a nitric oxide releasing organometallic nitrosyl compound useful for the prevention of platelet aggregation
US6261594B1 (en) * 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US20040131753A1 (en) * 1999-10-08 2004-07-08 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses therefor
US20040093015A1 (en) * 2002-08-01 2004-05-13 Ogle Matthew F. Embolism protection devices
WO2004012874A1 (en) * 2002-08-02 2004-02-12 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same

Also Published As

Publication number Publication date
WO2006064056A2 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
WO2006064056A3 (en) Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
WO2004065423A3 (en) Recognition molecules for the treatment and detection of tumours
EP2696203A3 (en) Tumor cell-derived microvesicles
WO2009149179A3 (en) Enhanced antiviral therapy methods and devices
EP2596744A3 (en) Guide member
HK1096392A1 (en) Substituted heterocycles
WO2006018632A3 (en) Cell therapy with exo 1
WO2006076651A3 (en) Treatment method
MX2010007038A (en) Microorganisms for improving the health of individuals with disorders related to gluten ingestion.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
IL203982B (en) Devices for generating air with allicin
WO2006076003A3 (en) Vaccinia virus strains
WO2006023452A3 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
EP3741362A3 (en) Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration, tumor targeting and cancer metastasis treatment, methods of production and uses thereof
WO2007028154A3 (en) Encapsulated arsenic drugs
WO2008157787A3 (en) Hydroxylated tolans and related compounds in the treatment of cancer
WO2007001453A3 (en) Glycerin based synthesis of silver nanoparticles and nanowires
WO2008053484A3 (en) Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy
WO2004082366A3 (en) Methods to confer enhanced floral properties to plants
WO2013109279A3 (en) Stabilization of the anti-cd20 antibody rituximab
HK1106253A1 (en) Desoxo-nonadepsipeptides
WO2008116956A3 (en) Peptides with capacity for binding with interleukine 10 (il - 10)
WO2010042633A3 (en) Naringenin complexes and methods of use thereof
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05821707

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 5821707

Country of ref document: EP